BridgeBio Pharma CEO Neil Kumar receives 71,216 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
BridgeBio Pharma, Inc. (BBIO) reported that CEO Neil Kumar received 71,216 common shares when RSUs vested on November 16, 2026. 36,236 shares were withheld for taxes at $77.36 per share. The four RSU tranches vest quarterly after their initial vesting dates, subject to continued service. The report lists indirect holdings of 495,686 shares in Kumar Haldea Family Irrevocable Trust, 750,000 shares in NK 2026 GRAT and 3,568,447 shares in Kumar Haldea Revocable Trust; Kumar disclaims beneficial ownership except to the extent of any pecuniary interest.
Insider Trade Summary
71,216 shares exercised/converted
Exercise
9 txns
Insider
Kumar Neil
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F5 | 33,544 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F1, F6 | 19,599 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F1, F7 | 11,554 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F1, F8 | 6,519 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 33,544 | -- | -- |
| Exercise | Common Stock F1 | 19,599 | -- | -- |
| Exercise | Common Stock F1 | 11,554 | -- | -- |
| Exercise | Common Stock F1 | 6,519 | -- | -- |
| Tax Withholding | Common Stock F2 | 36,236 | $77.36 | $2.80M |
| Holding | Common Stock F3 | -- | -- | -- |
| Holding | Common Stock F4 | -- | -- | -- |
| Holding | Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 320,280 units (Direct);
Common Stock — 278,307 shares (Direct);
Common Stock — 495,686 shares (Indirect, By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.);
Common Stock — 750,000 shares (Indirect, By NK 2026 GRAT);
Common Stock — 3,568,447 shares (Indirect, By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.)
Footnotes (8)
- F1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- F2. Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 71,216 shares of Common Stock underlying the Reporting Person's RSUs.
- F3. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
- F4. These shares are held by the NK 2026 GRAT, a grantor retained annuity trust of which the Reporting Person is the sole trustee and sole annuitant. The Reporting Person disclaims beneficial ownership of the shares held by the NK 2026 GRAT except to the extent of his pecuniary interest therein.
- F5. The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
- F6. The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
- F7. The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2025. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
- F8. The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2026. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
Key Figures
RSUs vested: 71,216 shares
Shares withheld for taxes: 36,236 shares
Withholding price: $77.36 per share
+3 more
6 metrics
RSUs vested
71,216 shares
November 16, 2026; the units represented contingent rights to receive common shares
Shares withheld for taxes
36,236 shares
November 16, 2026; withheld to satisfy the tax obligation related to RSU vesting
Withholding price
$77.36 per share
November 16, 2026; shares withheld to satisfy the tax obligation
Kumar Haldea Family Irrevocable Trust holdings
495,686 shares
Indirect common-stock holdings reported November 16, 2026
NK 2026 GRAT holdings
750,000 shares
Indirect common-stock holdings reported November 16, 2026
Kumar Haldea Revocable Trust holdings
3,568,447 shares
Indirect common-stock holdings reported November 16, 2026
Key Terms
Restricted Stock Unit, grantor retained annuity trust, pecuniary interest
3 terms
Restricted Stock Unit financial
"Each Restricted Stock Unit represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
grantor retained annuity trust technical
"the NK 2026 GRAT, a grantor retained annuity trust"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
pecuniary interest financial
"except to the extent of his pecuniary interest therein"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the vesting terms for Neil Kumar’s BBIO RSUs?
The RSUs vested as to 1/16th of the underlying shares on each award’s initial date: May 16, 2023, May 16, 2024, May 16, 2025, or May 16, 2026, respectively. Thereafter, 1/16th vests quarterly, subject to continued service with BridgeBio or a subsidiary. The RSUs have no expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.